Ampio puts $7M into Denver facility; Cambrex API plant gets FDA OK; Hanford scores low-cost volts;

> Ampio Pharmaceuticals will spend $7 million to equip a site in the Denver Tech Center of Colorado, so that it can manufacture commercial-scale versions of its investigational product. Report

> L.B. Bohle, which manufactures pharmaceutical processing and handling equipment, has spent about $6.8 million to build a new manufacturing facility in Ennigerloh, Germany. Release

> Cambrex says its active pharmaceutical ingredient plant in Charles City, IA, has passed an FDA inspection with no Form 483 observations. Report

> The FDA has posted a job listing to hire a new director for its office of compliance. Listing

> Novartis' ($NVS) generic unit Sandoz says that it had started a late-stage clinical trial with its biosimilar version of AbbVie's ($ABV) best-selling drug Humira, the sixth biosimilar to go into Phase III trials. Story

> The FDA says that compounder Abrams Royal Pharmacy is voluntarily recalling all unexpired lots of sterile products dispensed nationwide due to concerns of lack of sterility assurance.

And Finally... Hanford Pharmaceuticals in Syracuse, NY, will get low-cost electricity through a state program in exchange for adding 54 jobs as part of a manufacturing plant expansion. Story